Literature DB >> 9125131

Fas/APO-1(CD95)-induced apoptosis of primary hepatocytes is inhibited by cAMP.

K E Fladmark1, B T Gjertsen, S O Døskeland, O K Vintermyr.   

Abstract

Fas/APO-1(CD-95) activation induced rapid apoptotic cell death of primary rat hepatocytes in suspension culture. Activators of cAMP-dependent protein kinase (glucagon and N6-benzoyl-cAMP) protected against apoptosis, whereas the specific cAMP-kinase inhibitor (Rp)-8-Br-cAMPS enhanced Fas-induced death. The latter observation indicated that even the basal cAMP level may provide partial protection against Fas-induced hepatocyte apoptosis. Two-dimensional gel electrophoresis revealed decreased phosphorylation of several proteins in Fas-activated cells. Most of these dephosphorylations were attenuated or not observed in cells simultaneously stimulated by anti-Fas and cAMP, indicating a tight correlation between the dephosphorylations and death. Elevation of cAMP rescued the cells not only from the Fas-induced morphological changes and dephosphorylation, but also from functional deterioration. Whereas cells treated with anti-Fas alone quickly lost plating efficiency, hepatocytes co-treated with glucagon retained their ability to adhere and spread on a collagen substratum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125131     DOI: 10.1006/bbrc.1997.6214

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Aberrant expression of cAMP-response-element-binding protein ('CREB') induces apoptosis.

Authors:  K Saeki; A Yuo; E Suzuki; Y Yazaki; F Takaku
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

2.  The effects of cell density, attachment substratum and dexamethasone on spontaneous apoptosis of rat hepatocytes in primary culture.

Authors:  L Qiao; G C Farrell
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Jul-Aug       Impact factor: 2.416

3.  Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis.

Authors:  Luca Benetti; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

4.  Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4.

Authors:  Leila Gobejishvili; Shirish Barve; Katja Breitkopf-Heinlein; Yan Li; JingWen Zhang; Diana V Avila; Steven Dooley; Craig J McClain
Journal:  J Pharmacol Exp Ther       Date:  2013-07-25       Impact factor: 4.030

5.  Synergistic effect of cAMP and palmitate in promoting altered mitochondrial function and cell death in HepG2 cells.

Authors:  Linxia Zhang; Linsey C Seitz; Amy M Abramczyk; Christina Chan
Journal:  Exp Cell Res       Date:  2009-12-21       Impact factor: 3.905

6.  Attenuation of macrophage apoptosis by the cAMP-signaling system.

Authors:  A von Knethen; B Brüne
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

7.  CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal.

Authors:  W Chen; Y L Yu; S F Lee; Y J Chiang; J R Chao; J H Huang; J H Chiong; C J Huang; M Z Lai; H F Yang-Yen; J J Yen
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

Review 8.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

9.  Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia.

Authors:  J Zheng; A Ghorpade; D Niemann; R L Cotter; M R Thylin; L Epstein; J M Swartz; R B Shepard; X Liu; A Nukuna; H E Gendelman
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

10.  NO-Evoked macrophage apoptosis is attenuated by cAMP-induced gene expression.

Authors:  A von Knethen; F Brockhaus; I Kleiter; B Brüne
Journal:  Mol Med       Date:  1999-10       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.